Zya Enzymes Ltd

Based in the UK, Zya Enzymes Ltd specializes in enzyme-based innovations that enhance the nutritional value of food products while preserving their taste and texture. Zya Enzymes Ltd develops enzyme technologies aimed at improving food nutrition. Founded by Josh Sauer and Niels Wicke, the company is headquartered in London, UK. The company has raised GBP 1.

907 mn in funding, with the most recent deal occurring on June 15, 2022, involving investment from Exerte Partners. This funding has contributed to a current company valuation of GBP 9. 646 mn. Zya specializes in enzyme-based innovations that enhance the nutritional profile of food products without compromising taste or texture.

Their flagship product, Convero, is a naturally-derived enzyme that transforms 30% of sugar into dietary fiber during digestion, thereby reducing sugar content and increasing fiber intake simultaneously. This innovative solution addresses the growing consumer demand for healthier food options while allowing food brands to maintain the flavor and texture that end users enjoy. Zya’s clients primarily consist of food manufacturers and brands looking to improve their product offerings across various markets, including North America and Europe. Zya generates revenue through partnerships with food brands and manufacturers that incorporate their enzyme technology into existing products.

This B2B structure allows Zya to align with companies interested in enhancing their nutritional offerings while preserving the sensory qualities that consumers expect. Transactions typically involve licensing agreements where clients pay for the use of Zya's proprietary enzymes, such as Convero, in their products. Specific pricing plans and transaction structures are established on a case-by-case basis, depending on the scale of integration and the specific needs of the client. Through these partnerships, Zya facilitates a mutually beneficial relationship focused on advancing nutritional outcomes while supporting their clients' business goals.

In June 2022, Zya Enzymes Ltd raised GBP 1. 9 million of venture funding from Exerte Partners, which will support their expansion efforts. The company plans to design new enzyme products to meet evolving consumer demands and aims to penetrate new markets in North America and Europe by the end of 2024. This strategy will enable Zya to enhance its product lineup and expand its customer base, positioning itself for sustained growth.